The autism spectrum disorders (ASD) comprise a complex group of behaviorally related disorders that are primarily genetic in origin. Involvement of epigenetic regulatory mechanisms in the pathogenesis of ASD has been suggested by the occurrence of ASD in patients with disorders arising from epigenetic mutations (fragile X syndrome) or that involve key epigenetic regulatory factors (Rett syndrome). Moreover, the most common recurrent cytogenetic abnormalities in ASD involve maternally derived duplications of the imprinted domain on chromosome 15q11 -13. Thus, parent of origin effects on sharing and linkage to imprinted regions on chromosomes 15q and 7q suggest that these regions warrant specific examination from an epigenetic perspective, particularly because epigenetic modifications do not change the primary genomic sequence, allowing risk epialleles to evade detection using standard screening strategies. This review examines the potential role of epigenetic factors in the etiology of ASD.
INTRODUCTION
It is widely held that the autism spectrum disorders (ASD), including autism, Asperger disorder, childhood disintegrative disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS) are largely genetic in origin, with a polygenic, epistatic model best fitting the family, twin and epidemiological data for non-syndromic forms. The number of interacting loci contributing to susceptibility has been estimated to range between two and 15 genes of varying effect (1, 2) . Despite considerable effort over the past decade, these underlying risk alleles have been remarkably elusive, with the exception of a handful of rare, large effect genes (3 -5) and several single gene disorders associated with an increased risk for autism or ASD (6 -11) . Although this likely reflects the underlying genetic heterogeneity within and among the diagnostic categories in the ASD, the obstacles encountered in mapping the risk alleles have led a number of investigators to rethink the model of inheritance to include contributions of new mutations and/or epigenetic mechanisms such as genomic imprinting or epimutations in the underlying genetic susceptibility to ASD (12, 13) .
Epigenetic modifications including cytosine methylation and post-translational modification of histones provide a mechanism for modulation of gene expression that can be influenced by exposure to environmental factors and that may show parent of origin effects. Involvement of epigenetic factors in ASD is demonstrated by the central role of epigenetic regulatory mechanisms in the pathogenesis of Rett syndrome and fragile X syndrome (FXS), single gene disorders commonly associated with ASD (12, 14, 15) . Rett syndrome, included among the ASD in the Diagnostic and Statistical Manual, IV, is a complex neurological disorder that arises from mutation in the gene that encodes the methyl-CpG-binding protein 2 (MeCP2), one of the key mediators of epigenetic regulation of gene expression (9) . As its name implies, MeCP2 binds methylated cytosine residues and interacts with chromatin remodeling complexes to generate repressive chromatin structures of the surrounding DNA (16 -18) . In contrast, FXS arises through a combination of genetic and epigenetic mutation, wherein expansion of a CGG repeat in the 5 0 -untranslated region of the FMR1 gene, renders the region susceptible to epigenetic silencing, resulting in loss of expression of the gene (15) .
Genomic imprinting is the classic example of regulation of gene expression via epigenetic modifications that leads to parent of origin-specific gene expression. In addition, a growing number of genes that are not imprinted are regulated by DNA methylation, including Reelin (RELN ) (19 -23) , which has been considered as a candidate for autism (24 -28) . Because DNA methylation can be modified by mutation (10) , maternal exposures (29 -31) and postnatal experiences (32 -34) , it provides a tangible link between gene and environment. For example, in the viable yellow agouti mouse strain # The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org (A vy ), coat color ranges from yellow to agouti based on the degree of methylation of an IAP element that lies in the promoter of the Agouti locus. The coat color trait is incompletely heritable and influenced by the mother's and not by the father's epigenotype (31) . Moreover, modification of the maternal diet during gestation affects methylation of the locus, reflected in variations in coat color in genetically identical mice (29, 31) .
In autism, the primary strategies for identifying susceptibility alleles have revolved around genome-wide and targeted analyses of allele sharing in sib-pairs, using association studies and transmission disequilibrium testing (TDT) of functional (15)] and involve the imprinted genomic region that is deleted in Prader Willi syndrome (PWS) and Angelman syndrome (AS). In addition to ASD, the phenotype of the dup(15) syndrome includes variable degrees of cognitive impairment, motor delays, seizures and dysmorphic facial features, which may be subtle (48,50 -53) . Like PWS and AS, parent of origin effects on phenotypic expression are evident (48) , and it is the maternally derived duplications that confer a high risk of ASD (.85%). In contrast, rare reports of paternally derived duplications suggest that they lead to mild developmental and cognitive deficits (48, 52, 54, 55) , with only one case reported who had PDD-NOS in conjunction with borderline mental retardation, which did not co-segregate with the interstitial duplication in the family (56) . The maternal origin of the duplicated chromosome in autistic patients with dup(15) syndrome focuses attention to the maternally expressed genes, although it is likely that misexpression of both imprinted and biallelically expressed genes contribute (57) ( Fig. 1 and Table 2 ). Regulation of gene expression for this segment of the genome is particularly complex and involves differential methylation and expression of antisense and noncoding RNAs (58) . A number of genes are subject to tissue and/or developmentally regulated monoallelic expression including at least two genes that are expressed preferentially from the maternal chromosome in brain: UBE3A, the gene that causes AS, and ATP10A, which lies 200 kb telomeric to UBE3A and encodes a putative human aminophospholipidtransporting ATPase (59) . Within the duplicated segment in both idic (15) and int dup (15) , imprinting is maintained and transcription of the additional maternal copies of UBE3A (60) translates into increased levels of the gene product, the E6-AP ubiquitin protein ligase, with a commensurate disturbance of ubiquitin-mediated protein turnover (57) .
Notably, the commonly duplicated segment also encompasses several paternally expressed genes that might be considered functional candidates for ASD. These include two genes that are expressed in brain and encode proteins important for neuronal development, NECDIN (NDN ) (61 -63) and MAGE-like 2 (MAGEL2) (64 -67) . NDN is expressed in postmitotic neurons and plays a critical role in the specification of inhibitory neurons in the brain via interaction with distal-less 5 (DLX5), the product of a maternally expressed gene that lies on chromosome 7q that has also been implicated in ASD (discussed subsequently) (68) . MAGEL2 is an intronless gene located in close proximity to the NDN locus. It is transcribed from the paternal allele and expressed predominantly in hypothalamus, making it a strong candidate for the eating disorder in PWS (64 -66) . Although these genes are strong candidates in PWS and potential functional candidates in ASD, it is difficult to rectify the apparent conflict between the consequences of additional copies of paternally expressed genes and the maternal-origin of the autism phenotype in dup(15) syndrome. However, given the complexities of regulation of gene expression in this region, it is possible that duplications on the maternal chromosome indirectly lead to misexpression of paternal genes by interfering with proper pairing (69) or by imbalances between sense and antisense transcripts (70) .
Recent studies of autistic behaviors among patients with PWS arising from maternal uniparental disomy (UPD) compared with those with paternal deletions support the contribution of imprinted and non-imprinted genes on chromosome 15q in the development of ASD. Although patients with maternal UPD have significantly higher scores on measures of autistic behaviors, the frequency of ASD among these patients does not approach that seen in dup (15) syndrome (71 -73) . Because maternal UPD results in expression of both copies of the maternally expressed genes but does not interfere with expression of non-imprinted genes in the region, this argues that, indeed, the maternally expressed transcripts contribute to the ASD susceptibility in dup(15) syndrome but are not, in and of themselves, sufficient to cause ASD. Consistent with this idea, genome-wide expression profiling using lymphoblasts from dup(15) patients identified over 100 consistently dysregulated transcripts, most of which arose from genes outside the duplication (57). Thus, even in dup (15) syndrome, it appears that the autism phenotype is an incompletely penetrant, multigenic trait.
CHROMOSOME 15Q: EVIDENCE FOR A ROLE IN AUTISM IN CYTOGENETICALLY NORMAL PATIENTS
Perhaps surprisingly, genome-wide screens have not consistently identified evidence for linkage to chromosome 15 in ASD cohorts, although application of targeted high-density screening strategies or phenotypic subgroupings has defined a region of interest that extends from the PWS/AS critical region through the cluster of genes encoding g-aminobutyric acid (GABA) receptor subunits (49, 51, (74) (75) (76) (77) (78) (79) (80) (81) (82) (83) (84) . The numerous imprinted and biallelically expressed genes that lie in this region are thus positional candidates, with the genes encoding GABA receptor subunits (GABRB3, GABRA5, GABRG3) of particular interest in ASD because of their function in the nervous system. Both of the maternally expressed genes that lie toward the centromeric end of the candidate region have been specifically investigated in ASD. Using high-density, targeted screening strategies, linkage disequilibrium was detected at both the UBE3A and ATP10A loci in families with autism (75,76) ; however, mutation screening in two small cohorts of autistic patients did not identify clearly pathological mutations in these genes (77, 85) . Subsequent studies in postmortem brain samples from patients with autism revealed abnormalities in methylation of the UBE3A CpG island (13) as well as decreased UBE3A/E6-AP expression in autism, AS and Rett samples (12, 13) , suggesting that UBE3A misexpression may be a common mechanism for these phenotypically related disorders.
Similarly, the GABA receptor gene cluster (GABRB3, GABRA5, GABRG3), which lies toward the telomeric end of the ASD candidate region, has also received considerable attention. As the principal inhibitory neurotransmitter, GABA is a key regulator of excitability in the mammalian central nervous system. GABA receptor expression is regulated both regionally and developmentally and abnormalities in receptor expression have been detected in autistic brains (12,86 -88) . Disruption of development of GABAergic interneurons in mice leads to complex neurodevelopmental effects with similarity to ASD including deficits in socialization, seizures and anxiety (89) . Further, autism and ASD are common features in succinic acid dehydrogenase deficiency, a rare autosomal recessive disorder that arises from loss of the enzyme that metabolizes GABA to succinic acid (90) . Together, these data suggest that imbalances in GABAergic function may be a central deficit in the neurobiology of autism and ASD.
From the genetic standpoint, several studies identified evidence for linkage or association with the GABA receptor genes on chromosome 15q in autism samples, particularly GABRB3 (49,78,79,83,91 -93) ; although as commonly occurs in this field, not all groups replicated the finding (81, 94) . Recent studies of this group of genes in ASD focused on identification of potential interactions among alleles in different GABA receptor genes using a complex modeling system designed to reveal epistatic relationships. Although there was no strong evidence for interaction among the three genes on chromosome 15q12(99), extension of these analyses to GABA receptor genes on other chromosomes yielded significant results with positive associations between alleles for GABRA4 and GABRB1 on chromosome 4p and autism (93) . This region has been previously implicated by linkage (43) and by the identification of chromosome rearrangements involving 4p12 in patients with autism (95, 96) .
Imprinting and epigenetics of chromosome 7q in ASD
One of the first regions identified in linkage studies in ASD encompassed most of the long arm of chromosome 7, and subsequent analyses indicated that this likely reflects linkage two (or more) susceptibility loci on chromosome 7q (Fig. 2) . The more centromeric linkage peak(s) lie at 103.63 -125.95 cM on 7q21-31.31. Using parent of origin linkage modeling, Lamb et al. identified a region of excess paternal sharing with a maximum lod score of 1.46 for identity by descent for paternal alleles at 112 cM (35), near an imprinted gene cluster (105 -110 cM) in a region of conserved synteny with mouse chromosome 6 (97) ( Table 3 ). In humans, the cluster includes two paternally expressed genes, SGCE (encoding sarcoglycan epsilon) and the retro-transposon derived paternally expressed gene 10 (PEG10), both of which were found to be binding targets for Mecp2 in mouse (98) . Additionally, the paraoxonase 1 gene (PON1), which has been examined as a candidate gene in ASD (99 -101) , was expressed preferentially from the paternal chromosome in human:mouse somatic cell hybrids (102) . This gene has been extensively evaluated in cardiovascular disease and no evidence for parent of origin effects on allele transmission has been detected in humans or mice (103, 104) , arguing against imprinting in vivo.
Two genes are maternally expressed, PPP1R9A (protein phosphatase 1, regulatory subunit 9A) and DLX5 (distal-less homeobox transcription factor 5), and there is evidence for maternal expression of the calcitonin receptor (CALCR) gene in both humans (102) and mice (105) . Additionally, three other genes have some evidence for tissue-specific maternal expression in mice, but their imprinting status is not known in humans. These include the Asb4 gene(Ankyrin repeat and SOCS box containing 4) (106) and two other paraoxonase paralogs, Pon2 and Pon3, which were shown to be maternally expressed only in murine extraembryonic tissues (107) .
DLX5 has been examined as a candidate gene for ASD. DLX5 is a particularly attractive candidate that is a member of a gene family that encodes a group of homeobox transcription factors that play critical roles in development of the nervous system. DLX5 and DLX2 directly regulate expression of glutamic acid decarboxylase, the enzyme that produces the neurotransmitter GABA (108) . As such, these proteins are central to the specification and function of inhibitory GABAergic neurons in the mammalian forebrain, a population of neurons that have been implicated in the pathogenesis of autism (109, 110) . The DLX5 gene lies in a tail-to-tail configuration with another family member, DLX6, and on chromosome 2q, the DLX1 and DLX2 genes are similarly oriented and also in proximity to a region of interest in autism. An ultraconserved intergenic enhancer region that lies at the 3 0 end of the associated genes coordinates tissue specific and developmental expression of the gene pairs (111) , and Mecp2, the protein that is deficient in the ASD, Rett syndrome, participates in the process (98) . Because of the central role of the DLX proteins in GABAergic systems and the location of the gene pairs under ASD linkage peaks, Hamilton et al. examined the DLX1/2 and DLX5/6 pairs in a cohort of 161 patients with autism and 378 controls using a direct sequencing approach. A number of novel sequence variants were identified in both groups; however, none was de novo and examination of the segregation of the variations within and between families did not provide conclusive evidence supporting the genes as susceptibility alleles (112) . Similarly, a recent study of the ultraconserved regions on chromosome 7q, including those surrounding DLX5, did not identify sequence variations that could be clearly associated with ASD (113) . In both studies, the authors cautiously concluded that these loci could not be definitively associated with autism, although they each identified sequence variants that potentially affected expression or function of these genes. With this in mind and given the role for MeCP2 and chromatin-based regulation for the DLX5/DLX6 (107, 167, 168) I, imprinted; NI, not imprinted; CD, conflicting data; NO, no ortholog; PD, preliminary data.
pair (98), however, it would be of interest to re-evaluate these genes from an epigenetic perspective.
On the distal long arm of chromosome 7 lies another region that has been linked to autism by several groups (35 -37,39,43,114 -116) . Overlap of the linkage peaks suggests the possibility of two loci, one centered on 7q32.2 and the other on 7q35 -36.2. Of note, two studies have detected parent of origin effects on sharing of alleles at chromosome 7q32.2, which encompasses another imprinted domain that includes one maternally expressed and four paternally expressed genes (Table 4) . CPA4, which encodes a secreted metallocarboxypeptidase, is the only maternally expressed gene that has been identified in this region and is not an obvious functional candidate for autism. The four paternally expressed transcripts include (i) mesodermally expressed transcript (MEST ); (ii) MESTIT1, which generates an antisense transcript from common promoter; (iii) the g2 subunit of the coatamer protein complex (COPG2) and (iv) an intronic, antisense transcript from this gene (COPG2IT1). In a study that was the first of its kind, this gene cluster was examined from an epigenetic perspective in a subset of 46 autism families selected from the International Molecular Genetics Study of Autism Collaboration (IMGSAC) sample based on allele sharing for markers within the 7q32 region. Using sequence and TDT analyses, they did not detect evidence for pathological mutations nor did they detect differences in allele transmissions for CPA1, CPA5, MEST and COPG2. They extended the studies to examine potential epigenetic mutations using a Southern blot based strategy to examine the differentially methylated regions in MEST and COPG2 and also examined replication timing across the region. Again, no abnormalities were detected in the autism group (117) . Similar to the investigation of the DLX genes, the authors concluded that these data indicate that these genes are unlikely contributors to the etiology of autism. Nonetheless, it remains possible that epimutations are occurring in a tissue-specific manner or that important methylation sites were not detected using the Southern approach. Given the recurrence of linkage to this region and the parent of origin effect on sharing, further study of these genes is warranted including expression analysis and a thorough examination of methylation.
Imprinting and the X chromosome
One of the truly enigmatic aspects of autism genetics has been rectifying the basis of the gender bias of these disorders, which show a roughly 4-fold excess of affected males across the ASD population. This gender bias is maintained even with exclusion of patients with mutations in known X-linked genes that can cause ASD (FMR1 and MECP2), although it becomes less apparent in cohorts with more severe cognitive impairment. Although the most obvious explanation is involvement of an X-linked gene of major effect, the relative rarity of clearly X-linked pedigrees and lack of consistent linkage to the X chromosome suggest that the mechanism is more complex. Like ASD, many complex traits show gender differences in frequency, implying a difference in susceptibility that may be genetic and/or endocrine in origin. In a classic multigenic epistatic model for transmission, one would predict a higher rate of recurrence among families of probands of the less affected gender who presumably carry an increased number of susceptibility alleles. Family-based studies in ASD have consistently failed to support this prediction, however, with similar recurrence risks and an excess of affected males among relatives of male and female probands.
In 1997, Skuse et al. (118, 119) proposed an intriguing hypothesis involving epigenetic mechanisms to explain the gender bias in ASD based on his work on social cognition and executive function in females with Turner syndrome (45,X). In a study of 80 females with monosomy X, the parent of origin of the X-chromosome impacted performance on measures of social cognition with better performance by females with paternally derived X chromosomes (118) . The investigators proposed the existence of an imprinted locus, which they tentatively mapped to Xq or proximal Xp, that increased social behaviors in females and hence, conferred protection to females against ASD (and other disorders affecting social and language skills). In this model, the locus is silenced on the maternally derived X chromosome and thus not expressed in males, rendering them more vulnerable to impairments in social and communication skills (120 -123) . Consistent with this model, karyotypically normal females performed better on these measures than normal males and autism and/or ASD have been reported in females with 45,X mat Turner syndrome (123) and Xp deletions (124) .
This model has been somewhat controversial, in part, because the parent of origin effect on behavior has not been observed by other investigators (125) , but also because of difficulties in mapping the locus. Thus, the recent discovery of a cluster of imprinted genes on the mouse X chromosome has generated considerable interest (126, 127) . These genes, Xl3b, Xl4b and Xl4c are maternally expressed, escape X inactivation and lie in a region of conserved synteny with human chromosome Xq28, although human orthologs have not been identified. Notably, the model had predicted a gene that was expressed from the paternal X chromosome; however, it remains to be seen whether these genes directly contribute to behavior in mice and whether there are human counterparts that are similarly imprinted. Nonetheless, this discovery opens the door toward understanding whether there is indeed a role for one or more imprinted X-linked genes underlying the gender bias in ASD.
CONCLUSION
The past few years have seen advances in our understanding of the genetic basis of autism and ASD, with the discovery of mutations in genes of major effect including NLGN3 and NLGN4 (5) and CACNA1C, which encodes the alpha-1c subunit of the type I voltage-dependent calcium channel (7) . Although mutations in these genes may not be common among the autistic population (4, 8, (128) (129) (130) (131) , they shed light on pathways that are important in the ASD. Moreover, a growing body of data implicate a central role for GABAergic systems in these disorders (12,80,87-89,92,93,96,132 -134) . Additionally the role of epigenetic factors in the basic etiology of FXS and Rett syndrome, two single gene disorders associated with autism and ASD, clearly indicates that proper regulation of gene expression via epigenetic mechanisms is critical for development of the neural circuits involved in social behaviors, language and cognition in humans; the parent of origin effect on chromosome 15q duplications indicates that one (or more) of the imprinted genes in the region participate in the susceptibility to ASD associated with this disorder.
Methylation of DNA not only serves to mediate repression of gene expression in imprinted domains, but also provides a mechanism through which environmental factors can have long-lasting effects on the genome. How imprinting or methylation-based regulation of gene expression contribute to the loci that confer autism susceptibility remains to be seen. Because the standard approaches used in genome mapping do not assay DNA methylation, a risk conferred by variation of an epiallele would not be detected by sequencebased strategies. Thus, as the field continues to progress, with refinement of the areas of recurrent linkage by increasing sample sizes and the application of high resolution SNP typing and HapMap strategies in study of the ASD, it will be prudent to keep in mind the importance of epigenetic modifications in the regions of interest and to develop high throughput approaches to screen samples of adequate size to definitively determine their role in ASD.
